Back

Impact of TAVR on GDMT in patients with severe aortic stenosis and HFrEF

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Treating heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jason Galo

Georgetown University, Washington, DC (United States of America)

4 More presentations in this session

Presentation thumbnail
Ivabradine improves win ratios of outcomes in HFrEF patients
Associate Professor A. Abdin (Homburg, DE)
Abstract Slides Video
Presentation thumbnail
Association of atrial fibrillation with heart failure measurements of the HeartLogic multi-sensor remote monitoring algorithm: data from the DANLOGIC-HF trial
Doctor F. Fussing (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Safety and long-term outcomes of heart failure drug minimization in patients with improved ejection fraction: SLIM-HF study
Doctor Y. Luo (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Perception versus perception decoded using a pan indian survey on the awareness and utilization of GDMT in heart failure in India
Doctor P. Jayagopal (Palakkad, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Treating heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources